| Literature DB >> 35287182 |
Christine Tara Peterson1, Josue Perez Santiago2, Stanislav N Iablokov3, Deepak Chopra4, Dmitry A Rodionov5, Scott N Peterson6.
Abstract
Many studies have focused on the metabolic capacity of human gut microbiota to produce short-chain fatty acids and subsequent effects on host physiology. Given scarce data on how SCFAs produced by gut bacteria participate in cross-feeding to influence community structure and function, we evaluated the potential of SCFAs to modulate human gut microbiota in vitro. We employed anaerobic fecal cultivation in chemically defined medium supplemented with one of nine SCFAs to determine effects on both gut microbial community structure via 16S rRNA sequencing and function via genome reconstruction analysis. Each SCFA displayed significant and unique modulatory potential with respect to the relative abundance of bacterial taxa. Analysis of SCFA-supplemented communities revealed that alterations of individual closely related phylotypes displayed coherent changes, although exceptions were also observed which suggest strain-dependent differences in SCFA-induced changes. We used genome reconstruction to evaluate the functional implications of SCFA-mediated restructuring of fecal communities. We note that some SCFA-supplemented cultures displayed a reduction in the predicted abundance of SCFA producers, which suggests a possible undefined negative feedback mechanism. We conclude that SCFAs are not simply end-products of metabolism but also serve to modulate the gut microbiota through cross-feeding that alters the fitness of specified taxa. These results are important in the identification of prebiotics that elevate specific SCFAs for therapeutic benefit and highlight SCFA consumers as a salient part of the overall metabolic flux pertaining to bacterial fermentative processes.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35287182 PMCID: PMC8921067 DOI: 10.1007/s00284-022-02825-5
Source DB: PubMed Journal: Curr Microbiol ISSN: 0343-8651 Impact factor: 2.343
Fig. 1Principal component analysis of SCFA-supplemented cultures. a Bray–Curtis β diversity measures of control cultures compared to those supplemented with SCFAs. b Alpha diversity. Shannon diversity measures for control cultures compared to those observed in CDM supplemented with a single SCFA. c Modulatory effects of SCFAs. The average relative abundance of individual taxa in SCFA-supplemented cultures was compared to control cultures. Taxa displaying increased or decreased relative abundance (>fivefold) and the sum of these groups were summed and reported as altered. Taxa displaying changes < fivefold relative to control cultures were summed and reported as unaltered
Fig. 2Alterations at the phylum and family level by SCFAs. a The average relative abundance of individual taxa belonging to one of four phyla was summed for each SCFA-supplemented cultures and compared control cultures. b Alterations in dominant families by SCFAs. c Alterations in families of lower abundance by SCFAs
Fig. 3SCFA supplementation alters the representation of SCFA biosynthetic capacity. The relative abundance of communities (y-axis) predicted capacity to synthesize SCFAs and products of fermentation (x-axis) are depicted for each tested SCFA-supplemented culture (colored bars) (Color figure online)
Fig. 4SCFA supplementation alters the representation of vitamin biosynthetic capacity. The relative abundance of communities (y-axis) predicted capacity to synthesize vitamins (x-axis) are depicted for each tested SCFA-supplemented culture (colored bars) (Color figure online)
Fig. 5SCFA supplementation alters the representation of amino acid degradation pathways. The relative abundance of communities (y-axis) predicted capacity to degrade amino acids (x-axis) are depicted for each tested SCFA-supplemented culture (colored bars) (Color figure online)